RANK receptor oligomerisation in the regulation of NFκB signalling

Area of Science:

• Cell Biology
• Molecular Biology
• Immunology

Background:

• Receptor activator of NFκB (RANK) signaling is vital for osteoclast biology.
• The cytoplasmic oligomerization domain (PLAD) role in RANK signaling was previously unstudied.
• Mutations in TNFRSF11A lacking PLAD cause osteopetrosis, providing a model for study.

Purpose of the Study:

• To investigate the function of the PLAD in RANK signaling and osteoclastogenesis.
• To determine if PLAD is required for ligand-dependent or independent RANK activation.
• To assess the therapeutic potential of targeting PLAD for osteoporosis.

Main Methods:

• TALEN-mediated gene editing in RAW264.7 cells to mimic W434X mutation.
• Overexpression studies of wild-type (WT) RANK, G280X-RANK, and W434X-RANK.
• Analysis of osteoclast-like cell formation and NFκB signaling pathways.

Main Results:

• W434X mutation impaired osteoclast-like cell formation.
• Absence of PLAD prevented ligand-independent but not ligand-dependent RANK oligomerization.
• Ligand-induced NFκB signaling occurred even without a complete PLAD.

Conclusions:

• The PLAD is not essential for ligand-dependent RANK oligomerization and NFκB activation.
• Osteoclast formation and function can proceed without a functional PLAD.
• Therapeutic strategies targeting RANK's PLAD for osteoporosis may be less effective than anticipated.